Malaria remains a major global health problem, particularly in tropical regions, and increasing resistance of Plasmodium falciparum to antimalarial drugs necessitates the discovery of new therapeutic candidates. This study aimed to identify potential PfGST inhibitors among 26 compounds from R.heudelotii seeds and evaluate their druglikeness and pharmacokinetic profiles. Molecular docking against PfGST (PDB ID: 1OKT) was performed using Molecular Operating Environment (MOE) 2022.02, followed by ADMET prediction using pkCSM. All compounds showed negative binding energies, indicating favorable interactions with PfGST. The primary candidate was selected by considering binding affinity, RMSD, Lipinski’s Rule of Five, pharmacokinetic properties, and toxicity.5-hydroxy-1-isopropyl-6,6-dimethyl-5-phenyl-piperidin-2-one showed a binding energy of ‒9.5780 kcal/mol and an RMSD of 1.2172 Å. The compounds complied with Lipinski’s criteria and was predicted to have no Ames toxicity or hepatotoxicity, indicating a more balanced druglike profile. Therefore, this compound was identified as the most promising candidate for further investigation as a potential PfGST targeted antimalarial agent. These findings support the use of an integrated docking and ADMET approach to prioritize natural compunds before experimental antimalarial evaluation in vitro.
Copyrights © 2026